keyword
https://read.qxmd.com/read/37300238/a-comparison-of-ankle-fractures-relative-to-other-fragility-fractures-a-review-and-analysis-of-the-american-orthopaedic-association-s-own-the-bone-database
#21
JOURNAL ARTICLE
Eric So, Christopher Juels, Ryan T Scott, Debra L Sietsema
BACKGROUND: Ankle fragility fractures (AFX) continue to increase in the elderly population. There is limited knowledge of AFX characteristics compared to nonankle fragility fractures (NAFX). The American Orthopaedic Association's Own the Bone (OTB) is a fragility fracture initiative. This robust data set was used to examine and compare characteristics of patients presenting with AFX to those with NAFX. METHODS: The OTB database contained 72,617 fragility fractures between January 2009 and March of 2022 and were reviewed in our secondary cohort comparative analysis...
June 9, 2023: Foot & Ankle International
https://read.qxmd.com/read/37204069/fine-needle-aspiration-cytopathology-of-pleomorphic-dermal-sarcoma
#22
JOURNAL ARTICLE
Bindu S Challa, Jose A Plaza, Paul E Wakely
INTRODUCTION: Pleomorphic dermal sarcoma (PDS) is an uncommon cutaneous mesenchymal neoplasm. It is cytomorphologically identical to atypical fibroxanthoma (AFX), but differs due to its invasion beyond the dermis. We undertook an examination of our experience with fine needle aspiration (FNA) biopsy cytology of PDS. MATERIALS AND METHODS: Our cytopathology files were searched for examples of PDS with concomitant histopathological verification. FNA biopsy smears and cell collection were performed using standard techniques...
May 19, 2023: Cytopathology: Official Journal of the British Society for Clinical Cytology
https://read.qxmd.com/read/37127912/cutaneous-sarcoma-a-review-and-practical-approach-to%C3%A2-management
#23
JOURNAL ARTICLE
Sophie Stoneham, Alys Hunter, Mina Raahimi, Amy Livesey, Charles D Mitchell, Stephen Keohane
Sarcomas arising in the skin are rare but potentially fatal. These tumours originate from mesenchymal cells and can be divided between those that arise in soft tissue and those arising from bone. General guidelines exist for the management of soft-tissue sarcomas; however, there are no specific guidelines for cutaneous sarcomas. Current literature was reviewed for management of seven cutaneous sarcomas including atypical fibroxanthoma, pleomorphic dermal sarcoma, dermal and subcutaneous leiomyosarcoma, dermatofibroma sarcoma protuberans, Kaposi sarcoma, cutaneous angiosarcoma and malignant peripheral nerve sheath tumour...
July 21, 2023: Clinical and Experimental Dermatology
https://read.qxmd.com/read/37070937/silicone-oil-tamponade-removal-which-technique-is-more-effective-an-x-ray-photoemission-spectroscopy-study
#24
JOURNAL ARTICLE
Tommaso Rossi, Paolo Canepa, Ornella Cavalleri, Ranieri Rolandi, Giorgio Querzoli, Isabella D'Agostino, Serena Telani, Guido Ripandelli
PURPOSE: To compare the efficacy of two surgical techniques used to remove silicone oil (SiO) emulsion tamponade after pars plana vitrectomy: triple air-fluid exchange (AFX) and balanced salt solution lavage (BSSL). METHODS: X-ray photoemission spectroscopy measured silicon content of the dry residue of fluid samples taken during AFX and BSSL. Ten patients underwent AFX and five BSSL. Three fluid samples were taken per patient, and the dry residue of 10 drops per sample were analyzed...
April 3, 2023: Translational Vision Science & Technology
https://read.qxmd.com/read/37068528/five-year-results-of-the-leopard-trial-of-commercially-available-endografts
#25
JOURNAL ARTICLE
Christopher J Kwolek, Kenneth Ouriel, Fred S Stucky, Vikram K Rao, Peter J Pons, Samuel E Wilson, Scott W Kujath
OBJECTIVE: The LEOPARD (Looking at EVAR Outcomes by Primary Analysis of Randomized Data) trial is a randomized controlled trial (RCT) comparing the outcomes of endovascular aneurysm repair (EVAR) using commercially available devices in a real-world population. METHODS: A prospective, randomized, multi-center trial was performed to compare the anatomically fixated (AF) AFX/AFX2 endograft system (Endologix, Irvine, CA) to endografts with proximal fixation (PF) (Cook Medical Zenith Flex, Bloomington, IN; Gore Excluder, Flagstaff, AZ; and Medtronic Endurant II, Minneapolis, MN) in patients with infrarenal abdominal aortic aneurysms (AAA)...
April 15, 2023: Journal of Vascular Surgery
https://read.qxmd.com/read/37050330/microleakage-and-marginal-integrity-of-ormocer-methacrylate-based-bulk-fill-resin-restorations-in-mod-cavities-sem-and-stereomicroscopic-evaluation
#26
JOURNAL ARTICLE
Aslı A Şenol, Büşra Karabulut Gençer, Bilge Tarçın, Erkut Kahramanoğlu, Pınar Yılmaz Atalı
This in vitro study aimed to compare the microleakage and marginal integrity of methacrylate/ormocer-based bulk-fill composite (BFC) restorations used in cervical marginal relocation with two different layering thicknesses in mesio-occlusal-distal (MOD) cavities exposed to thermo-mechanical loading. Standard MOD cavities were prepared in 60 mandibular molars and assigned into three groups: x-tra fil/AF + x-tra base/XB, Tetric N-Ceram Bulk Fill/TNB + Tetric N-Flow Bulk Fill/TFB, and Admira Fusion x-tra/AFX + Admira Fusion x-base/AFB...
March 30, 2023: Polymers
https://read.qxmd.com/read/37039274/in-vivo-reflectance-confocal-microscopy-findings-in-a-case-of-atypical-fibroxanthoma
#27
JOURNAL ARTICLE
Nilay Duman, Banu Yaman, Göktürk Oraloğlu, Işıl Karaarslan
Clinical and dermoscopic features of atypical fibroxanthoma (AFX) are mostly non-diagnostic, so other in vivo diagnostic tools may give additional clues for accurate clinical diagnosis, such as in vivo reflectance confocal microscopy (RCM). However, there has been scarce data on RCM features of AFX in the literature, in only clear cell type. Herein we present a case of epithelioid cell predominant type AFX with RCM findings.
April 11, 2023: Australasian Journal of Dermatology
https://read.qxmd.com/read/37037259/risk-for-surgical-interventions-following-endovascular-aneurysm-repair-with-endologix-afx-or-afx2-endovascular-aaa-systems-compared-to-other-devices
#28
JOURNAL ARTICLE
Heather A Prentice, Elizabeth W Paxton, Jessica E Harris, Joy Garg, Thomas F Rehring, Nicolas A Nelken, Homayon Hajarizadeh, Jeffrey H Hsu, Robert W Chang
OBJECTIVE: To evaluate the risk for 90-day returns to care and long-term subsequent surgical interventions following primary endovascular aneurysm repair (EVAR) with an Endologix AFX Endovascular AAA System compared to three other high-volume endograft devices. METHODS: We conducted a matched cohort study using data from an integrated healthcare system's Endovascular Stent Graft Registry. Patients aged ≥18 years who underwent primary EVAR for AAA in the healthcare system from 1/1/2011-12/31/2017 comprised the eligible study sample...
April 8, 2023: Journal of Vascular Surgery
https://read.qxmd.com/read/37035902/atypical-fibroxanthoma-and-pleomorphic-dermal-sarcoma-gene-expression-analysis-compared-with-undifferentiated-cutaneous-squamous-cell-carcinoma
#29
JOURNAL ARTICLE
Iris Marie Anders, Carolin Schimmelpfennig, Karolin Wiedemann, Dennis Löffler, Christoph Kämpf, Conny Blumert, Kristin Reiche, Manfred Kunz, Ulf Anderegg, Jan-Christoph Simon, Mirjana Ziemer
BACKGROUND: The histogenetic origin of atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS) has not been definitively elucidated. In addition to a fibroblastic origin, a keratinocytic differentiation is discussed due to strong clinical, histomorphological and molecular genetic similarities with undifferentiated cutaneous squamous cell carcinoma (cSCC). PATIENTS AND METHODS: 56 cases (36 AFXs, 8 PDSs, 12 undifferentiated cSCCs) were evaluated for their clinical, histomorphological, and immunohistochemical characteristics...
April 10, 2023: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/36997195/late-type-iii-endoleak-after-loss-of-component-overlap-after-evar-with-afx2-device-a-case-report
#30
Myeonghyeon Ko, Sanghyun Ahn, Seung-Kee Min, Ahram Han
Addressing the high incidence of late type III endoleaks in previous AFX models, Endologix upgraded the device material and updated its recommendation regarding component overlap. However, whether upgraded AFX2 models are safe for endoleaks remains controversial. Here we report a case of a 67-year-old male with an AFX2-implanted abdominal aortic aneurysm experiencing a delayed type IIIa endoleak. Aneurysmal sac enlargement occurred 36 months post-endovascular aneurysm repair (EVAR), with a computed tomography scan at 52 months revealing component overlap loss and a significant type IIIa endoleak...
March 30, 2023: Vascular Specialist International
https://read.qxmd.com/read/36866664/comparison-of-unibody-and-non-unibody-endografts-for-abdominal-aortic-aneurysm-repair-in-medicare-beneficiaries-the-safe-aaa-study
#31
JOURNAL ARTICLE
Eric A Secemsky, Yang Song, Tianyu Sun, Carmen Gacchina Johnson, Megan Gatski, Li Wang, Andrew Farb, Robert E Lee, Aurko Shaw, Jiaman Xu, Robert W Yeh
BACKGROUND: Concerns have been raised about the long-term performance of aortic stent grafts for the treatment of abdominal aortic aneurysms, in particular, unibody stent grafts (eg, Endologix AFX AAA stent grafts). Only limited data sets are available to evaluate the long-term risks related to these devices. The SAFE-AAA Study (Comparison of Unibody and Non-Unibody Endografts for Abdominal Aortic Aneurysm Repair in Medicare Beneficiaries Study) was designed with the Food and Drug Administration to provide a longitudinal assessment of the safety of unibody aortic stent grafts among Medicare beneficiaries...
April 25, 2023: Circulation
https://read.qxmd.com/read/36788920/a-rare-case-of-atypical-fibroxanthoma-of-the-thigh-in-an-elderly-patient
#32
Yaser Alotaibi, Mohammed F Bondagji, Abdulrahman M Alharthi, Abdullah Alharbi
Atypical fibroxanthoma (AFX) is a rare low-grade soft tissue tumor that manifests in sun-damaged skin on the head or neck of elderly patients, although it can occur anywhere else in the body. In this case, we report the presence of AFX on the right thigh of a 70-year-old white female. Upon presentation, she complained of a painless mass on her thigh with no family history of AFX or sun exposure. The mass had previously been managed by incision and drainage, with no improvement. The patient underwent a biopsy, revealing a diagnosis of AFX, which was managed by surgical removal of the neoplasm with appropriate safety margins...
January 2023: Curēus
https://read.qxmd.com/read/36764930/atypical-fibroxanthoma-outcomes-from-a-large-single-institution-series
#33
JOURNAL ARTICLE
Erin McClure, Michael J Carr, Ayushi Patel, Syed Mahrukh Hussnain Naqvi, Youngchul Kim, Michael Harrington, Wayne Cruse, Ricardo J Gonzalez, Vernon K Sondak, Amod A Sarnaik, Jane L Messina, Jonathan S Zager
BACKGROUND: Atypical fibroxanthomas (AFX) are rare malignant cutaneous neoplasms. Unfortunately, limited clinicopathologic and outcomes data on this cancer exists. OBJECTIVE: We report the clinical, pathologic, and treatment characteristics, as well as oncologic outcomes in this single-institution retrospective analysis. METHODS: This retrospective cohort study compiled clinical, pathologic, treatment, and outcome data for all patients with AFX on definitive excision diagnosed, evaluated, and treated primarily by surgical resection at a single institution between 2000-2020...
2023: Cancer Control: Journal of the Moffitt Cancer Center
https://read.qxmd.com/read/36732203/expression-of-satb2-in-primary-cutaneous-sarcomatoid-neoplasms-a-potential-diagnostic-pitfall
#34
JOURNAL ARTICLE
Julianne M Szczepanski, Javed Siddiqui, Rajiv M Patel, Paul W Harms, Steven M Hrycaj, May P Chan
SATB2 can be used as an immunohistochemical marker for osteoblastic differentiation. The differential diagnosis of a cutaneous sarcomatoid neoplasm sometimes includes osteosarcoma when the tumour concomitantly involves the skin, soft tissue, and bone, or when there is a past medical history of osteosarcoma. As the utility of SATB2 immunohistochemistry in these scenarios was unclear, we aimed to determine the frequency and the pattern of SATB2 expression in a variety of cutaneous sarcomatoid neoplasms. SATB2 expression by immunohistochemistry was evaluated by intensity (0-3) and extent (0-100%) of staining to generate an h-score for each case...
January 10, 2023: Pathology
https://read.qxmd.com/read/36644261/endovascular-repair-for-abdominal-aneurysm-with-concomitant-aortoiliac-vein-fistula-diagnosed-by-four-dimensional-computed-tomography
#35
JOURNAL ARTICLE
Chiharu Tanaka, Hidekazu Furuya, Shunsuke Kamei, Satoshi Suda, Masaomi Yamaguchi
A 78-year-old man complaining of left leg swelling was diagnosed with an abdominal aortic aneurysm with an irregular margin. A four-dimensional computed tomography (CT) showed an aortoiliac vein fistula. An AFX stent graft was urgently implanted, and a Viabahn VBX was inserted into the left iliac vein. The aneurysmal sac was embolized. After the procedure, enhanced CT confirmed a patent stent graft without any endoleak or fistula. The patient was discharged ambulatory. An aortoiliac vein fistula is a differential diagnosis for leg edema, and a four-dimensional CT is beneficial in diagnosing the condition...
December 25, 2022: Annals of Vascular Diseases
https://read.qxmd.com/read/36588868/the-potential-of-afx-iliac-extension-in-abdominal-aortic-aneurysms-with-high-iliac-tortuosity
#36
JOURNAL ARTICLE
Yuta Kikuchi, Norifumi Ohtani, Hiroyuki Kamiya
Recently, endovascular aortic aneurysm repair (EVAR) is the most common surgery for abdominal aortic aneurysm (AAA). However, iliac limb complications of EVAR often cause problems in patients with high iliac tortuosity. There is no difference of rate of iliac limb complication among EVAR devices, such as Excluder, Endurant, and Zenith in high iliac tortuosity. But there has been not reported about AFX. We studied AFX iliac extension as it is the only stent graft with an endoskeletal framework. This study aimed to evaluate the AFX iliac extension patency in a case in vitro and to use it in seven cases of AAA with high iliac tortuosity...
December 2022: International Journal of Angiology: Official Publication of the International College of Angiology, Inc
https://read.qxmd.com/read/36508370/zunahme-des-atypischen-fibroxanthoms-und-pleomorphen-dermalen-sarkoms-eine-retrospektive-analyse-vier-deutscher-hauttumorzentren
#37
JOURNAL ARTICLE
Thomas Kuntz, Julian Siebdrath, Silke C Hofmann, Mehmet Baltaci, Jörg Schaller, Martin Hellmich, Luise Stach von Goltzheim, Chalid Assaf, Frank Oellig, Alena-Lioba Michalowitz, Doris Helbig, Alexander Kreuter
HINTERGRUND UND ZIELE: In den letzten Jahren konnten umfassende Erkenntnisse über die Pathogenese, Diagnostik und Behandlung von kutanen Sarkomen, insbesondere des atypischen Fibroxanthoms (AFX) und pleomorphen dermalen Sarkoms (PDS) gesammelt werden. Beide Entitäten zeigten innerhalb der letzten Dekade steigende Inzidenzraten. Die vorliegende Studie diente der Untersuchung, welchen Einfluss die neuen Erkenntnisse auf die Fallzahlen von AFX/PDS im Vergleich zu anderen Sarkom-Entitäten haben...
December 2022: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
https://read.qxmd.com/read/36503020/outcomes-of-endovascular-reconstructive-techniques-in-trans-atlantic-inter-society-consensus-ii-c-d-aortoiliac-lesions
#38
JOURNAL ARTICLE
Sergio Zacà, Claudio Desantis, Lucia Di Stefano, Raffaele Pulli, Domenico Angiletta
BACKGROUND: To describe the outcomes of the endovascular reconstruction of TASC C/D lesions involving the infrarenal aorta and aortic bifurcation with different techniques. METHODS: This is an observational, retrospective, single-center study. In a 5-year period, we selected all the patients treated with an endovascular procedure for an aorto-iliac TASC C/D lesion involving the infrarenal aorta and/or the aortic bifurcation. Early (<30 days) outcomes were mortality, major amputation, and thrombosis...
March 2023: Annals of Vascular Surgery
https://read.qxmd.com/read/36446119/margin-size-for-unique-skin-tumors-treated-with-mohs-micrographic-surgery-a-survey-of-practice-patterns
#39
JOURNAL ARTICLE
Frances M Walocko, Christian Carr, Divya Srivastava, Rajiv I Nijhawan
Mohs micrographic surgery (MMS) has shown lower recurrence rates for unique skin tumors compared with wide local excision, but there is a lack of standardization on margin size. We aimed to assess MMS practice patterns of margin sizes for unique skin tumors. A survey was distributed to members of the American College of Mohs Surgery (ACMS). Demographic information on participants was collected in addition to initial/subsequent MMS margin size for unique skin tumors, including dermatofibrosarcoma protuberans (DFSP), atypical fibroxanthoma (AFX), melanoma, sebaceous carcinoma, microcystic adnexal carcinoma (MAC), poorly differentiated squamous cell carcinoma (SCC), and Merkel cell carcinoma...
September 2022: Cutis; Cutaneous Medicine for the Practitioner
https://read.qxmd.com/read/36442137/increase-of-atypical-fibroxanthoma-and-pleomorphic-dermal-sarcoma-a-retrospective-analysis-of-four-german-skin-cancer-centers
#40
JOURNAL ARTICLE
Thomas Kuntz, Julian Siebdrath, Silke C Hofmann, Mehmet Baltaci, Jörg Schaller, Martin Hellmich, Luise Stach von Goltzheim, Chalid Assaf, Frank Oellig, Alena-Lioba Michalowitz, Doris Helbig, Alexander Kreuter
BACKGROUND AND OBJECTIVES: In recent years, considerable insight has been gained into the pathogenesis, diagnosis and treatment of cutaneous sarcomas, including atypical fibroxanthoma (AFX) and pleomorphic dermal sarcoma (PDS). Both entities have shown increasing incidence rates in the last decade. This study was initiated to evaluate how these new insights impact the number of diagnoses of AFX/PDS compared to other cutaneous sarcoma entities. PATIENTS AND METHODS: In a retrospective study of four German skin cancer centers, all histopathological reports of cutaneous sarcomas (AFX, PDS, dermatofibrosarcoma protuberans, cutaneous leiomyosarcoma, angiosarcoma, and Kaposi sarcoma) confirmed by board-certified dermatopathologists were analyzed during a time-period of seven years (2013-2019)...
November 28, 2022: Journal der Deutschen Dermatologischen Gesellschaft: JDDG
keyword
keyword
161808
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.